Search - tctmd.com

Displaying 21 - 40 of 66

Sort: Relevancy | Date

Presentation ESC 2024

RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence

Presenter: Derek Chew

September 02, 2024

Presentation ESC 2024

Optical coherence tomography-guided coronary intervention in patients with complex lesions: The OCCUPI Randomized Clinical Trial

Presenter: Byeong-Keuk Kim

September 02, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Presentation ESC 2024

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Presenter: Ling Tao

September 02, 2024

News Conference News ESC 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

Shelley Wood

September 02, 2024

Presentation ESC 2024

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presenter: Manesh R. Patel

September 01, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

Presentation ESC 2024

A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation on Cardiovascular Outcomes in Rural China

Presenter: Minglong Chen

September 01, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

Presentation ESC 2024

The EARTH-STEMI IPD meta-analysis

Presenter: Gianluca Campo

September 01, 2024

Presentation ESC 2024

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Presenter: Dipak Kotecha

September 01, 2024

Presentation ESC 2024

Randomized invitation to systematic NT-proBNP and ECG screening in 75- year olds to detect atrial fibrillation – STROKESTOP II

Presenter: Katrin Kemp Gudmundsdottir

September 01, 2024

Presentation ESC 2024

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

Presenter: Pardeep S. Jhund

September 01, 2024

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Todd Neale

September 01, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Todd Neale

August 31, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

Advertisement

RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence

Optical coherence tomography-guided coronary intervention in patients with complex lesions: The OCCUPI Randomized Clinical Trial

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation on Cardiovascular Outcomes in Rural China

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

The EARTH-STEMI IPD meta-analysis

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Randomized invitation to systematic NT-proBNP and ECG screening in 75- year olds to detect atrial fibrillation – STROKESTOP II

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content